Literature DB >> 9192975

Mechanism of hyperthermic potentiation of cisplatin action in cisplatin-sensitive and -resistant tumour cells.

J V Hettinga1, W Lemstra, C Meijer, W A Dam, D R Uges, A W Konings, E G De Vries, H H Kampinga.   

Abstract

In this study, the mechanism(s) by which heat increases cis-diamminedichloroplatinum (cisplatin, cDDP) sensitivity in cDDP-sensitive and -resistant cell lines of murine as well as human origin were investigated. Heating cells at 43 degrees C during cDDP exposure was found to increase drug accumulation significantly in the cDDP-resistant cell lines but had little effect on drug accumulation in the cDDP-sensitive cell lines. DNA adduct formation, however, was significantly increased in all cell lines studied. Furthermore, ongoing formation of platinum (Pt)-DNA adducts after the end of cDDP treatment was enhanced and/or adduct removal was decreased in heated cells, resulting in relatively more DNA damage remaining at 24 h after the end of cDDP exposure. Correlation plots with survival revealed weak correlations with cellular Pt accumulation (r2 = 0.59) and initial Pt-DNA adduct formation (r2 = 0.64). Strong correlations, however, were found with Pt-DNA adducts at 6 h (r2 = 0.97) and 24 h (r2 = 0.89) after the incubation with the drug. In conclusion, the mechanism by which heat sensitizes cells for cDDP action seems to be the sum of multiple factors, which comprise heat effects on accumulation, adduct formation and adduct processing. This mechanism did not seem to differ between cDDP-sensitive and -resistant cells, emphasizing the potential of hyperthermia to reduce cDDP resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192975      PMCID: PMC2223603          DOI: 10.1038/bjc.1997.297

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

Review 1.  Hyperthermia and drugs.

Authors:  R Engelhardt
Journal:  Recent Results Cancer Res       Date:  1987

2.  Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.

Authors:  G A Hospers; N H Mulder; B de Jong; L de Ley; D R Uges; A M Fichtinger-Schepman; R J Scheper; E G de Vries
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

3.  cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II).

Authors:  A M Fichtinger-Schepman; A T van Oosterom; P H Lohman; F Berends
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

4.  Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.

Authors:  K Micetich; L A Zwelling; K W Kohn
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

5.  Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.

Authors:  A Eastman
Journal:  Chem Biol Interact       Date:  1987-03       Impact factor: 5.192

6.  Comparison of lipid content, surface membrane fluidity, and temperature dependence of cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

Authors:  S C Mann; P A Andrews; S B Howell
Journal:  Anticancer Res       Date:  1988 Nov-Dec       Impact factor: 2.480

7.  Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug.

Authors:  K E Wallner; M W DeGregorio; G C Li
Journal:  Cancer Res       Date:  1986-12       Impact factor: 12.701

8.  Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.

Authors:  T S Herman; B A Teicher; K N Cathcart; M E Kaufmann; J B Lee; M H Lee
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

9.  Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II).

Authors:  R E Meyn; P M Corry; S E Fletcher; M Demetriades
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

10.  Repair of UV-induced pyrimidine(6-4)pyrimidone photoproducts is selectively inhibited in transcriptionally active genes after heat treatment of human fibroblasts.

Authors:  R J Sakkers; A R Filon; H H Kampinga; A W Konings; L H Mullenders
Journal:  Int J Radiat Biol       Date:  1995-05       Impact factor: 2.694

View more
  9 in total

1.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

2.  Iron oxide nanoparticle hyperthermia and chemotherapy cancer treatment.

Authors:  Aa Petryk; Aj Giustini; P Ryan; Rr Strawbridge; Pj Hoopes
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2009-02-23

3.  Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications.

Authors:  Anastasia M Kruse; Samantha A Meenach; Kimberly W Anderson; J Zach Hilt
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

4.  Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.

Authors:  Antonio Macrì; Anna Fortugno; Edoardo Saladino
Journal:  World J Gastrointest Oncol       Date:  2011-12-15

Review 5.  Advances in the management of peritoneal malignancies.

Authors:  Vahan Kepenekian; Aditi Bhatt; Julien Péron; Mohammad Alyami; Nazim Benzerdjeb; Naoual Bakrin; Claire Falandry; Guillaume Passot; Pascal Rousset; Olivier Glehen
Journal:  Nat Rev Clin Oncol       Date:  2022-09-07       Impact factor: 65.011

Review 6.  Hyperthermic Intraperitoneal Chemotherapy in the Treatment Armamentarium of Epithelial Ovarian Cancer: Time to End the Dichotomy.

Authors:  Aditi Bhatt; Olivier Glehen
Journal:  Visc Med       Date:  2022-01-10

Review 7.  The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.

Authors:  Aditi Bhatt; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-16

8.  Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies.

Authors:  O Monneuse; A C Beaujard; B Guibert; F N Gilly; P Mulsant; P Y Carry; M Benoit; O Glehen
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

9.  Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study.

Authors:  Annika Kurreck; Felix Gronau; Miguel Enrique Alberto Vilchez; Wiltrud Abels; Philipp Enghard; Andreas Brandl; Roland Francis; Bettina Föhre; Christian Lojewski; Johann Pratschke; Peter Thuss-Patience; Dominik Modest; Beate Rau; Linda Feldbrügge
Journal:  Ann Surg Oncol       Date:  2021-08-04       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.